Stockreport

Beam Therapeutics Announces Key R&D Appointments

Beam Therapeutics Inc.  (BEAM) 
PDF CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base [Read more]